Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children

Lotte Rasmussen*, Nicole Pratt, Elizabeth Roughead, Anna Moffat

*Kontaktforfatter for dette arbejde

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Abstrakt

    Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government’s Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD.

    OriginalsprogEngelsk
    TidsskriftJournal of Autism and Developmental Disorders
    Vol/bind49
    Udgave nummer1
    Sider (fra-til)227–235
    ISSN0162-3257
    DOI
    StatusUdgivet - jan. 2019

    Fingeraftryk Dyk ned i forskningsemnerne om 'Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children'. Sammen danner de et unikt fingeraftryk.

    Citationsformater